Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Galera Therapeutics Inc

GRTX
Current price
0.2 USD -0.008 USD (-3.77%)
Last closed 0.2 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 10 660 871 USD
Yield for 12 month -93.25 %
1Y
3Y
5Y
10Y
15Y
GRTX
21.11.2021 - 28.11.2021

Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule dismutase mimetic for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and for patients with HNC undergoing standard-of-care radiotherapy. It also develops rucosopasem manganese (rucosopasem) to augment the anti-cancer efficacy of stereotactic body radiation therapy in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is based in Malvern, Pennsylvania. Address: P.O. Box 134, Malvern, PA, United States, 19355

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

0.5 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

+88 000 USD

Current Year

-259 000 USD

Last Year

-114 000 USD

Current Quarter

-9 000 USD

Last Quarter

-127 000 USD

Key Figures GRTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -37 399 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -59.29 %
PEG Ratio
Return On Equity TTM -1063.11 %
Wall Street Target Price 0.5 USD
Revenue TTM
Book Value -2.48 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.91 USD
Diluted Eps TTM -0.91 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics GRTX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History GRTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation GRTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.1763
Price Book MRQ 29.3902

Financials GRTX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators GRTX

For 52 weeks

0.085 USD 3.59 USD
50 Day MA 0.19 USD
Shares Short Prior Month 2 793 016
200 Day MA 0.18 USD
Short Ratio 1.16
Shares Short 2 123 783
Short Percent 5.28 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

430.32 USD Microsoft Corporation +0.69 (+0.16%)
Detailed analytics

ETF funds


S

SX7EEX

14.75 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics